| J9271 | Injection, pembrolizumab, 1 mg | 9,000 | $40 | $378K |
| J0897 | Injection, denosumab, 1 mg | 4,500 | $20 | $85.5K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 870 | $70 | $58.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 440 | $100 | $45.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 290 | $70 | $20.4K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 20,250 | $1 | $20.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 160 | $120 | $19.2K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 50 | $330 | $16.6K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 7,140 | $1 | $14.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 80 | $140 | $10.7K |